Inhibition of PTEN expression results in activation of the PI3K-AKT pathway which plays a powerful role in promoting tumor progression, and cancer cells are ultrasensitive to even a subtle decrease in PTEN levels and activity, making PTEN an important therapeutic target for PCa therapy [15]. This evidence concerns the gene PTEN and neoplasm.